Centessa Pharmaceuticals plc (CNTA) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$207.69M | -3.3% |
| 2024 | -$201.06M | -17.4% |
| 2023 | -$171.28M | +19.3% |
| 2022 | -$212.26M | — |
| 2020 | -$10.44M | -106.6% |
| 2019 | -$5.05M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$207.69M | -3.3% |
| 2024 | -$201.06M | -17.4% |
| 2023 | -$171.28M | +19.3% |
| 2022 | -$212.26M | — |
| 2020 | -$10.44M | -106.6% |
| 2019 | -$5.05M | — |